Prevention of pre-eclampsia by early antiplatelet therapy.

@article{Beaufils1985PreventionOP,
  title={Prevention of pre-eclampsia by early antiplatelet therapy.},
  author={Michel Beaufils and Serge Uzan and R. Donsimoni and J C Colau},
  journal={Lancet},
  year={1985},
  volume={1 8433},
  pages={840-2}
}
102 patients at high risk of pre-eclampsia and/or fetal growth retardation were randomly allocated to treatment with 300 mg dipyridamole and 150 mg aspirin daily from 3 months' gestation onwards (group A) or to the control group (group B, no treatment). Group A was twice as likely as group B to have a normal pregnancy. Pre-eclampsia occurred in 6 patients in group B and none in group A. Major complications (fetal death or severe growth retardation) occurred in 9 patients in group B and none in… CONTINUE READING